ArticleJACS Au2026
Nanopore Fingerprinting of Neurodegenerative Proteins and Phosphoproteins within a Minute.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification and Discrimination of Sulfated and Unsulfated Gut-Hormone Biomarkers in Human Serum by Nanopore.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reliable identification of proteins and their post-translationally modified variants remains a formidable analytical challenge due to charge heterogeneity, sequence similarity, and comparable molecular weights. In this study, we demonstrate distinctive nanopore current fingerprints for clear identification of neurodegenerative disease-associated Tau protein and its phosphorylated variants using an asymmetric-electrolyte sensing system composed of different salts. The asymmetric configuration facilitates simultaneous detection of positively, neutrally, and negatively charged peptide fragments, resulting in 3.2-16-fold higher capture frequencies and 2.1-5.3-fold longer event durations, thereby yielding information-rich fingerprints that enhance protein recognition. Protein profiling was achieved within 1 min through integration with a droplet nanopore platform, which reduces sample consumption to the nanogram level while increasing throughput to >1800 events per minute. This work advances the nanopore fingerprinting approach for rapid, high-throughput, and low-sample protein biomarker detection, offering strong potential for clinical proteomics and early disease diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.